CLINICAL_TRIALS
trial_result
· 2009-09-25
Clinical Trial Update: A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) [Phase 2]
Summary
Phase 2 clinical trial of sitagliptin for type 2 diabetes mellitus has completed enrollment and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2009-09-25